CNR Institutional Research Information System

UGONE, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.012
NA - Nord America 678
EU - Europa 405
SA - Sud America 220
AF - Africa 31
OC - Oceania 1
Totale 2.347
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 636
SG - Singapore 464
CN - Cina 196
BR - Brasile 171
IT - Italia 169
HK - Hong Kong 127
VN - Vietnam 120
FR - Francia 69
NL - Olanda 37
AR - Argentina 22
GB - Regno Unito 20
FI - Finlandia 18
CA - Canada 16
MX - Messico 16
DE - Germania 15
IN - India 15
KR - Corea 14
EC - Ecuador 12
BD - Bangladesh 11
ID - Indonesia 11
AT - Austria 10
IE - Irlanda 10
JP - Giappone 9
SE - Svezia 9
ES - Italia 8
TR - Turchia 7
ZA - Sudafrica 7
UA - Ucraina 6
IQ - Iraq 5
MA - Marocco 5
PL - Polonia 5
PT - Portogallo 5
RO - Romania 5
CO - Colombia 4
LT - Lituania 4
PY - Paraguay 4
SA - Arabia Saudita 4
CL - Cile 3
DZ - Algeria 3
KZ - Kazakistan 3
NG - Nigeria 3
PK - Pakistan 3
RU - Federazione Russa 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
BF - Burkina Faso 2
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
CY - Cipro 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
OM - Oman 2
SN - Senegal 2
TH - Thailandia 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 2.347
Salva come PNG Salva come JPEG
Città #
Singapore 252
Santa Clara 220
Hong Kong 126
San Jose 56
Ashburn 53
Beijing 47
Lauterbourg 46
Los Angeles 45
Ho Chi Minh City 43
Hanoi 36
Hefei 28
Milan 28
São Paulo 27
Sala Baganza 26
Amsterdam 24
Guangzhou 17
Cavallino 16
Dallas 15
Lappeenranta 14
New York 14
Seoul 13
Orem 11
Vienna 10
Cagliari 9
Bitonto 8
Dublin 8
Frankfurt am Main 8
Genoa 8
Stockholm 8
Naples 7
Phoenix 7
Quito 7
Turin 7
Boardman 6
Poplar 6
Tokyo 6
Afragola 5
Bologna 5
Boston 5
Brasília 5
Brooklyn 5
Da Nang 5
Denver 5
Dhaka 5
Florence 5
Querétaro 5
Betim 4
Bucharest 4
Buffalo 4
Haiphong 4
Houston 4
Johannesburg 4
London 4
Montreal 4
Warsaw 4
Ananindeua 3
Belo Horizonte 3
Biên Hòa 3
Campinas 3
Chennai 3
Düsseldorf 3
Florianópolis 3
Paris 3
Portsmouth 3
Rio de Janeiro 3
Rome 3
Tempio Pausania 3
Trieste 3
Almaty 2
Antakya 2
Arapiraca 2
Atlanta 2
Baku 2
Blumenau 2
Brazzaville 2
Bridgetown 2
Bình Dương 2
Bình Dương Province 2
Cairo 2
Camaragibe 2
Can Tho 2
Cape Town 2
Caxias do Sul 2
Chicago 2
City of London 2
Council Bluffs 2
Curitiba 2
Dakar 2
Dores do Rio Preto 2
Dubai 2
Grand Rapids 2
Guayaquil 2
Helsinki 2
Ibadan 2
Irecê 2
Istanbul 2
Jakarta 2
Kyiv 2
Lahore 2
Louisville 2
Totale 1.451
Salva come PNG Salva come JPEG
Nome #
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 73
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 68
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 67
Covalent and non-covalent binding in vanadium-protein adducts 65
Vanadium-proteins. Structure, binding, characterization and biological implications 64
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 62
Antioxidant Properties and Radical Production Capability of the Potential Antitumor V(IV)O Complexes Formed by Flavonoid Ligands 61
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 61
Thermodynamic study of oxidovanadium(Iv) with kojic acid derivatives: A multi-technique approach 61
A Study on the Photoisomerization of (E)-Dehydrozingerone, Its (E)-(E)-C₂ Symmetric Dimer, and Their O-Methylated Derivatives 60
Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A 59
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug. 56
Speciation and biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 54
Influence of temperature on the equilibria of oxidovanadium(iv) complexes in solution 54
Nonoxido V(IV) complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 50
Interaction of the potent antitumoral compounds Casiopeinas® with blood serum and cellular bioligands 48
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 47
In-Depth Mass Spectrometry Study of Vanadium(IV) Complexes with Model Peptides 47
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability 46
Biotransformation of oxidovanadium(IV) complexes with oxydiacetate and NN-heterocycles 46
Interaction of vanadium(IV,V) coordination complexes with proteins 46
Speciation of vanadocene dichloride in the blood plasma 44
Interaction of pharmacologically active pyrone and pyridinone vanadium(IV,V) complexes with cytochrome c 44
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies 43
Biotransformation in the blood serum of potential antitumor V(IV)O2+ complexes and interaction with red blood cells 43
Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems 42
Characterization of oxidovanadium(IV) complexes with quinolones 42
Characterization and biotransformation in the plasma and red blood cells of VIVO2+ complexes formed by ceftriaxone 40
Novel porphyrin-containing hydrogels obtained by frontal polymerization: Synthesis, characterization and optical properties 40
Interaction of V(V) complexes formed by picolinic and pyrazinecarboxylic acid derivatives with red blood cells 40
Interaction of vanadocene dichloride with the blood serum components 39
Integrated instrumental/computational methods to characterize the binding to proteins and biospeciation of potential vanadium drugs 37
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 37
Equilibrium between Different Coordination Geometries in Oxidovanadium(IV) Complexes. 37
Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin 37
Interaction of potential vanadium drugs with proteins studied by an experimental and computational approach 36
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH. 36
Speciation of potential anti-diabetic vanadium complexes in real serum samples 35
Interaction of vanadium compounds with Cytochrome c 35
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug-myoglobin application 35
Biotransformation in the blood serum of potential antitumor V(IV)O2+ complexes and interaction with red blood cells 35
Binding of potential antitumor Casiopeínas® to small proteins 33
Interaction of Vanadium(IV) Species with Ubiquitin: A Combined Instrumental and Computational Approach 31
VO complexes with antibacterial quinolone ligands and their interaction with serum proteins. 30
Evaluation of antifungal and antimycotoxigenic activity of selected natural antioxidants against Fusarium culmorum: in vitro and in planta assays 30
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 30
Characterization of the coordination modes of flavonoids towards oxidovanadium(IV) 30
Decoding Surface Interaction of V(IV)O Metallodrug Candidates with Lysozyme 28
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 27
Integrative spectroscopic-docking methods for the study of the interaction between vanadium complexes and proteins 27
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 26
V(IV)O and V(IV) Species Formed in Aqueous Solution by the Tridentate Glutaroimide-Dioxime Ligand - An Instrumental and Computational Characterization 25
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations. 24
Synthesis, crystal structures, EPR and DFT studies of first row transition metal complexes of lignin model compound ethylvanillin 24
Temperature and Solvent Structure Dependence of VO2+ Complexes of Pyridine-N-oxide Derivatives 23
Complex formation between [(eta(6)-p-cym)Ru(H2O)(3)](2+) and oligopeptides containing three histidyl moieties 22
Effect of secondary interactions, steric hindrance and electric charge on the interaction of V(IV)O species with proteins 21
Estratto fenolico di bacche di mirto comune e composizione farmaceutica orale contenente il suddetto estratto in combinazione con un complesso di vanadio 10
Totale 2.413
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.773
article - articoli 5.768
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202458 0 0 0 0 0 0 0 0 26 9 15 8
2024/2025949 110 5 77 29 158 60 8 54 65 40 198 145
2025/20261.406 42 79 102 250 322 112 185 86 85 99 44 0
Totale 2.413